|
FosrenolDrug - Fosrenol The trade name of the product as shown on the labeling.
Dosage -
TABLET, CHEWABLE; ORAL
Active Ingredient(s) -
Lanthanum Carbonate
Strength -
EQ 500MG BASE
Applicant -
SHIRE
New Drug Application (NDA) Number -
021468
Product Number -
002
Therapeutic Equivalence (TE) Code -
Approval Date -
Oct 26, 2004
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Shire Development Inc
Fosrenol
Prevacid 15mg Tablet, Delayed Release, Orally Disintegrating; Oral
Prevacid 30mg Tablet, Delayed Release, Orally Disintegrating; Oral Naprapac 250 (copackaged) 15mg,n/a;n/a,250mg Capsule, Delayed Rel Pellets; Tablet; Oral Naprapac 375 (copackaged) 15mg,n/a;n/a,375mg Capsule, Delayed Rel Pellets; Tablet; Oral Naprapac 500 (copackaged) 15mg,n/a;n/a,500mg Capsule, Delayed Rel Pellets; Tablet; Oral Fosrenol Eq 250mg Base Tablet, Chewable; Oral Fosrenol Eq 500mg Base Tablet, Chewable; Oral Prevacid 15mg/packet For Suspension, Delayed Release; Oral Prevacid 30mg/packet For Suspension, Delayed Release; Oral Prevacid Iv 30mg/vial Injectable; Intravenous NewDrugInformation |